|
?:authorAffiliation
|
-
[\'Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.\', \'Dana-Farber Cancer Institute, Boston, MA.\', \'Department of Data Science, Harvard T. H. Chan School of Public Health, Boston, MA.\', \'Instituto de Investigación, Hospital Universitario 12 de Octubre (i+12), Madrid, Spain.\', \'Centro Nacional de Investigaciones Oncológicas (CNIO), Complutense University, Madrid, Spain.\', \'Leeds Institute of Clinical Trial Research and.\', \'Leeds Cancer Centre, University of Leeds, Leeds, United Kingdom.\', \'John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.\', \'Department of Haematology, University College London Hospitals National Health Service (NHS) Foundation Trust, London, United Kingdom.\', \'Clínica São Germano, São Paulo, Brazil.\', \'Medical Department.\', \'Hematology, Oncology and Stem Cell Transplantation, and.\', \'Clinical Cancer Research Group, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Myeloma Unit, Division of Hematology, University of Turin/Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.\', \'Department of Hematology, Hospital de Manises, Valencia, Spain.\', \'Hematology Laboratory, University of Turin, Turin, Italy.\', \'Department of Haematology, University Medical Centre, Utrecht, The Netherlands.\', \'Department of Hematology, University of Siena, Siena, Italy.\', \'Center for Myeloma, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY.\', \'Division of Hematology, Mayo Clinic, Rochester, MN.\', \'Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.\', \'Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.\', \'Department of Hematology, Ankara University, Ankara, Turkey.\', \'II Medizinische Klinik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.\', \'Department of Medical Oncology, Harvard Medical School, Boston, MA.\', \'Instituto de Investigación Biomédica de Salamanca (IBSAL), University Hospital of Salamanca, Salamanca, Spain.\', \'Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.\', \'Intergroupe Francophone du Myélome (IFM), Paris, France.\', \'Clínica Universidad de Navarra and.\', \'Centro de Investigacion Medica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain.\', \'Instituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain.\', \'Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Pamplona, Spain.\', \'US Department of Veterans Affairs (VA) Boston Healthcare System, Boston, MA; and.\', \'Centre de Recherche en Cancérologie de Toulouse, Unité 1037, INSERM, Toulouse, France.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}